IFS
IMUC

Ifrah Financial Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Ifrah Financial Services’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-463
Closed -$2K – 208
2016
Q3 		$2K Hold
463
– – ﹤0.01% 192
2016
Q2 		$4K Hold
463
– – ﹤0.01% 196
2016
Q1 		$5K Hold
463
– – ﹤0.01% 193
2015
Q4 		$7K Hold
463
– – ﹤0.01% 189
2015
Q3 		$8K Hold
463
– – ﹤0.01% 195
2015
Q2 		$9K Hold
463
– – ﹤0.01% 202
2015
Q1 		$9K Hold
463
– – ﹤0.01% 203
2014
Q4 		$14K Hold
463
– – 0.01% 198
2014
Q3 		$16K Hold
463
– – 0.01% 205
2014
Q2 		$21K Hold
463
– – 0.01% 200
2014
Q1 		$23K Hold
463
– – 0.01% 199
2013
Q4 		$17K Sell
463
-250
-35% -$23.7K 0.01% 192
2013
Q3 		$73K Buy
+713
New +$78.3K 0.04% 106

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return